Linde Gas & Equipment Inc.

Linde Gas & Equipment Inc., a foreign-owned global manufacturer of compressed and liquid industrial and medical gases headquartered in Danbury, Connecticut, operates as a prime contractor supplying specialized gases and related equipment to federal agencies on a full-and-open basis, with recent award activity concentrated heavily in the Defense Logistics Agency's SPE2DH medical gases program consolidation and ongoing operational supply contracts across 97 customer agencies. The company is a child entity of Linde Inc. (parent) and operates alongside subsidiaries including Praxair Distribution, Inc. and Praxair, Inc., which carry forward the Praxair brand identity in the federal marketplace—a legacy of Linde's 2018 acquisition of Praxair.

Linde Gas & Equipment's federal footprint centers on industrial gases serving three primary capability domains: compressed and bulk liquid medical gases (oxygen, nitrogen, nitrous oxide, carbon dioxide) for military and civilian healthcare facilities; analytical and specialty gases (helium-3, argon, nitrogen mixtures) for research, defense, and law enforcement operations; and related equipment rental, fill services, and delivery logistics. Primary NAICS representation spans 325120 (Industrial Gas Manufacturing) anchoring 475 of recent awards, supplemented by 424480 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers) for 51 awards, with PSC 6830 (Gases: Compressed and Liquefied) dominating 376 awards. Recent representative prime work includes $558 million in combined potential value across 69 Defense Logistics Agency medical gases contract awards under the SPE2DH program through September 2032, including a $40 million indefinite delivery contract (September 2025); $7.4 million in combined potential value across 12 awards from the National Institute of Environmental Health Sciences for miscellaneous bulk gases and gas cylinder tank deliveries, anchored by a $2.2 million indefinite delivery contract (December 2025); a $1.49 million Department of Energy delivery order for equipment usage fees (October 2024); and $471.2 thousand Food and Drug Administration purchase order for consumable gases and related products extending through February 2030.

Customer concentration is extreme. The Defense Logistics Agency Troop Support Medical (primarily SPE2DH medical gases contracts) accounts for $558 million—91% of the combined potential value across 69 awards—reflecting the consolidation of the Military Health System's medical gas procurement into national single-award indefinite delivery contracts awarded October 2025. The gap between award count (88 Naval Sea Systems Command awards, $2.2 million combined value) and dollar concentration illustrates the structural difference: NAVSEA places numerous small tactical orders for specialty gases and equipment; DLA anchors the portfolio with large, long-duration medical gas vehicles serving 100+ military medical treatment facilities across 12 geographic regions. The top five customer agencies by potential value (Defense Logistics Agency, NIEHS, Defense Logistics Agency Energy, Veterans Affairs, and Drug Enforcement Administration) account for approximately 94% of combined potential value across 170 awards.

Vehicle position reflects consolidation-driven strategy. The SPE2DH program awards dominate: Linde holds 30+ single-award indefinite delivery contracts under SPE2DH, each ranging from $800,000 to $40 million in ceiling, collectively exceeding $430 million through September 2032 for military healthcare medical gas supply. Beyond SPE2DH, major vehicles include an IDC with the National Institute of Environmental Health Sciences ($2.2 million through December 2030) for bulk gases to Research Triangle Park, North Carolina; an indefinite delivery contract with the Department of Energy ($243 thousand through September 2027); and a $2.06 million indefinite delivery contract with the Department of Veterans Affairs Technology Acquisition Center for medical cylinder gases and fills serving Veterans Integrated Service Network 15 facilities across Illinois, Kansas, and Missouri. Additional structure includes blanket purchase agreements such as EPBPA17B0002 (57 task orders, $63 thousand combined value) and W25G1V19A0009 (45 task orders, $23 thousand combined value) with the Army Communications Electronics Command and EPA, respectively, supporting standing-offer compressed gas delivery and chemical supply relationships.

Activity trajectory shows growth but uneven year-to-year execution. Awards per year climbed from 40 (2022) to 100 (2025), representing sustained engagement, but dropped to 33 through June 2026—likely reflecting the back-loaded timing of October 2025 SPE2DH award finalization. The recent award portfolio (880 total awards across the source period) reflects 98% prime positioning and only 2% sub-award participation, establishing Linde as a direct federal supplier rather than a teaming partner. Eleven awards are completing within the next twenty-four months with combined potential value of $3.4 million—modest recompete exposure relative to the $558 million SPE2DH portfolio, which does not enter recompete until 2032.

Subcontract footprint is limited and specialized. Named sub-award relationships include General Atomics (inertial confinement fusion target R&D support, supplying cryogenic and specialty gases); Amentum Services, Inc. (facility management support including cylinder rentals); Leidos, Inc. (Antarctic research logistics including gas supply); Northrop Grumman Systems Corporation (manufacturing support); Honeywell Federal Manufacturing & Technologies (weapons stewardship operations including cylinder fees); and Pantex Deterrence, LLC (weapons plant operations including gas rental and lease). These relationships represent direct supply of industrial and specialty gases to defense research, weapons stewardship, and federal facility operations rather than traditional teaming.

Federal grant sub-award activity is minimal: one sub-award to HRL Laboratories, LLC (April 2025) for helium cylinder supply under an unnamed research grant. The source indicates grant participation remains sparse relative to the contract footprint.

Linde Gas & Equipment competes predominantly full-and-open without set-aside designations—a reflection of the specialized nature of high-purity medical and analytical gases. The source flags a single Total Small Business set-aside award (Defense Health Agency CO2 dry ice nuggets purchase order, October 2024, $97.7 thousand). The military medical gases consolidation under SPE2DH was awarded as non-set-aside single-award contracts, indicating the Defense Logistics Agency determined competitive merit and technical capability—not small business preference—drove vendor selection.

The scale of activity in recent months reflects the October 2025 SPE2DH contract finalization, which restructured fragmented regional military healthcare gas purchasing into 30+ national indefinite delivery vehicles. This consolidation represents sustained, nine-year revenue opportunity (through September 2032) anchoring the portfolio's forward visibility, though delivery order execution against these vehicles remains the variable determining actual invoiced revenue. Prior indefinite delivery contracts with Veterans Affairs and NIEHS—collectively $4.26 million in ceiling—demonstrate Linde's established operational capability sustaining long-term federal medical gas relationships. The company's position as a critical infrastructure supplier for defense healthcare, civilian federal research facilities, and specialized gas users (law enforcement, weapons stewardship, research institutions) establishes persistent federal customer demand across recession-resistant mission categories.